It is envisioned that the method presented in this study would expand the application of SS in biomedical filed. © 2020 Wiley Periodicals, Inc.Another animal to human transmission of a coronavirus occurred in December 2019 on a live animal market in the Chinese city of Wuhan causing an epidemic in China, reaching now different continents. This minireview summarizes the research literature on the virological, clinical and epidemiological aspects of this epidemic published until end of February 2020. © 2020 The Authors. Microbial Biotechnology published by John Wiley &amp; Sons Ltd and Society for Applied Microbiology.Cannabidiol (CBD), a major metabolite of Cannabis sativa, is popularized as a medicinal product, with potential for analgesic, anti-inflammatory and antioxidant effects. CBD may hold promise as a treatment in rheumatic diseases, but evidence to date remains preclinical. Preclinical effects on pain and inflammation is encouraging, but clinical study is lacking with only a single study in knee osteoarthritis reporting promising effect on symptoms. CBD products are freely available over the counter and marketed as food supplements or wellness products. The World Health Organization has identified pure CBD as safe and without abuse potential, but products are not subject to drug regulatory standards leading to inconsistency in manufacturing practices and quality of products. Not only have molecular concentrations of CBD been identified as inaccurate, but there are concerns for contaminants including heavy metals, pesticides, microbes and mycotoxins, as well as added THC. Drug-drug interactions pose a potential risk due to metabolism via the CYP P450 enzyme pathway. Patients wishing to use CBD should obtain a product with certification of Good Manufacturing Practices, initiate treatment with a nighttime low dose and have defined outcome goals within a reasonable time frame. Treatments should not be managed by non-medical dispensary personnel. The hope that CBD may be a useful therapy must be substantiated by sound scientific study. This article is protected by copyright. https://www.selleckchem.com/peptide/octreotide-acetate.html All rights reserved.INTRODUCTION Sustained HIV viral suppression resulting from antiretroviral therapy (ART) eliminates the risk of HIV transmission, a concept popularly framed as Undetectable&nbsp;=&nbsp;Untransmittable (U&nbsp;=&nbsp;U). We explored knowledge and acceptance of information around the elimination of HIV transmission risk with ART (U&nbsp;=&nbsp;U) in Kenya. METHODS Our qualitative study was conducted within a project evaluating the use of pre-exposure prophylaxis (PrEP) integrated into ART care for HIV serodiscordant couples in public clinics in Kenya (the Partners Scale Up Project). From February 2017 to April 2019, we conducted semi-structured key informant interviews with 83 health providers and in-depth interviews with 61 HIV-negative people in serodiscordant relationships receiving PrEP services. Transcripts were coded using thematic analysis. RESULTS Health providers reported being aware of reduced risk of HIV transmission as a result of consistent ART use and used words such as "very low," "minimal" and "like zero" to describe HIV tra is both a lack of in-depth knowledge and conviction about the strategy among health providers and HIV-negative partners in serodiscordant relationships. New strategies that go beyond communicating the science of U&nbsp;=&nbsp;U to consider the local social and clinical environments could maximize the effectiveness of U&nbsp;=&nbsp;U. © 2020 The Authors. Journal of the International AIDS Society published by John Wiley &amp; Sons Ltd on behalf of the International AIDS Society.DNA-binding proteins play essential roles in many molecular functions and gene regulation. Therefore, it becomes highly desirable to develop effective computational techniques for detecting DNA-binding proteins. In this paper, we proposed a new method, iDBP-DEP, which performs DNA-binding prediction by using the discriminative feature derived from multi-view feature sources including evolutionary profile, dipeptide composition, and physicochemical properties with feature selection. We evaluated iDBP-DEP on two benchmark datasets, i.?e., PDB1075 and PDB594 by rigorous Jackknife test. Compared with the state-of-the-art sequence-based DNA-binding predictors, the proposed iDBP-DEP achieved 1.8?% and 3.0?% improvements of accuracy (Acc) and Mathew's Correlation Coefficient (MCC), respectively, on PDB1075 dataset; 7.4?% and 14.8?% improvements of Acc and MCC, respectively, on PDB594. The independent validation test with PDB186 show that the proposed method achieved the best performances on Acc (80.1?%) and MCC (0.684), which further demonstrated the robustness of iDBP-DEP for the detection of DNA-binding proteins. Datasets and codes used in this study are freely available at https//githup.com/Zll-codeside/iDBP-DEP. © 2020 Wiley-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.OBJECTIVE This study aimed to 1) analyze the criterion validity of the&nbsp;Slaughter equations (Slg-Eq) and bioelectrical impedance analysis (BIA) to estimate body fat percentage (BFP) and fat mass index (FMI) at different degrees of obesity in children compared with dual-energy x-ray absorptiometry (DXA) and 2) determine their agreement over time. METHODS Ninety-two children with overweight or obesity (10.0 [SD&nbsp;1.2] years; 34.8% girls) participated in this 20-week study. Anthropometric, BIA, and DXA measurements were performed. RESULTS Both Slg-Eq and BIA methods underestimated BFP and FMI against DXA, and the bias was markedly larger with BIA (mean absolute percentage error = 11% for Slg-Eq vs. 18%-21% for BIA); a larger underestimation was observed in girls compared with boys for Slg-Eq (P ? 0.001), and the observed underestimation in adiposity was reduced as weight status increased. Systematic errors were kept constant over time, so no large differences between methods were observed in the change in adiposity. CONCLUSIONS At the group level, Slg-Eq provides a more valid estimation of BFP and FMI than BIA. At the individual level, Slg-Eq shows larger estimation errors. The validity of these methods might differ in sex and weight status. Nevertheless, both methods seem to be valid for monitoring changes in adiposity. © 2020 The Obesity Society.